Die meistzitierten Artikel
|
Rang |
Autoren |
Paper |
Zitierungen |
1. | Stupp R, ..., Weller M, ..., Marosi C, Bogdahn U, Curschmann J, ..., Mirimanoff RO | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma NEJM 2005, 352(10):987-96 | 1148 |
2. | O‘Brien SG, ..., Gathmann I, ..., Fischer T, Hochhaus A, ..., Lechner K, ..., Gratwohl A, ..., Bolton AE, Capdeville R, Druker BJ | Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. NEJM 2003, 348(11):994-1004 | 907 |
3. | Piccart-Gebhart MJ, ..., Untch M, ..., Jackisch C, ..., Steger G, ..., Nitz U, ..., Thomssen C, ..., Rüschoff J, ..., Gelber RD | Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer NEJM 2005, 353(16):1659-72 | 843 |
4. | Wollert KC, ..., Arseniev L, Hertenstein B, Ganser A, Drexler H | Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. LANCET 2004, 364(9429):141-8 | 686 |
5. | Sauer R, ..., Wittekind C, ..., Raab R | Preoperative versus postoperative chemoradiotherapy for rectal cancer NEJM 2004, 351(17):1731-40 | 668 |
6. | Giaccone G, Herbst RS, Manegold C, ..., Gatzemeier U, ..., Johnson D | Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1. J CLIN ONCOL 2004, 22(5):777-84 | 636 |
7. | Heinrich MC, ..., Dimitrijevic S, Fletcher JA | Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J CLIN ONCOL 2003, 21(23):4342-9 | 619 |
8. | Hegi ME, ..., Weller M, ..., Stupp R | MGMT gene silencing and benefit from temozolomide in glioblastoma NEJM 2005, 352(10):997-1003 | 536 |
9. | Hanna N, ..., von Pawel J, Gatzemeier U, ..., Muller T, ..., Desch C, ..., Manegold C, ..., Bunn PA | Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy J CLIN ONCOL 2004, 22(9):1589-97 | 486 |
10. | Vogelzang NJ, ..., Gatzemeier U, ..., Manegold C, ..., Paoletti P | Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J CLIN ONCOL 2003, 21(14):2636-44 | 469 |
|